We are live on
!
Find out more
PG
Proffitt & Goodson Portfolio holdings
AUM
$728M
Turnover
11.9%
1-Year Est. Return
18.62%
This Fund
S&P 500
This Quarter
Est. Return
+1.61%
1 Year Est. Return
+18.62%
3 Year Est. Return
+48.49%
5 Year Est. Return
+42.28%
10 Year Est. Return
+158.21%
AUM
$172M
AUM Growth
+$2.17M
(+1.3%)
Cap. Flow
-$87.3K
Cap. Flow
% of AUM
-0.05%
Top 10 Holdings %
Top 10 Hldgs %
78.09%
Holding
40
New
–
Increased
10
Reduced
30
Closed
–
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.39M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$165K |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$58.8K |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$52K |
| 5 |
GE Aerospace
GE
|
+$37.5K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$299K |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$147K |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$145K |
| 5 |
Procter & Gamble
PG
|
+$131K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.26% |
| 2 | Technology | 3.91% |
| 3 | Healthcare | 3.32% |
| 4 | Communication Services | 3.2% |
| 5 | Consumer Staples | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$813B
| $53.1M | 30.97% |
257,365
-10,202
| -4% | -$2.11M |
2013 Q2
7 quarters
|
|
|
2
Vanguard FTSE Developed Markets ETF
VEA
$227B
| $22.6M | 13.2% |
568,445
+86,630
| +18% | +$3.39M |
2013 Q2
7 quarters
|
|
|
3
Vanguard Morningstar Total Stock Market ETF
VTI
$694B
| $21.2M | 12.38% |
197,994
-2,801
| -1% | -$299K |
2013 Q2
7 quarters
|
|
4
iShares Russell Mid-Cap ETF
IWR
$55.9B
| $8.51M | 4.96% |
196,520
+600
| +0.3% | +$25.5K |
2013 Q2
7 quarters
|
|
|
5
iShares Russell 2000 ETF
IWM
$76.4B
| $8.38M | 4.89% |
67,380
+1,366
| +2% | +$165K |
2013 Q2
7 quarters
|
|
6
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $8.08M | 4.71% |
197,640
-681
| -0.3% | -$27.7K |
2013 Q2
7 quarters
|
|
7
State Street Financial Select Sector SPDR ETF
XLF
$50.7B
| $6.17M | 3.6% |
291,486
-5,153
| -2% | -$109K |
2013 Q2
7 quarters
|
|
8
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
| $2.18M | 1.27% |
57,954
-1,698
| -3% | -$62.4K |
2013 Q2
7 quarters
|
|
9
Apple
AAPL
$5.01T
| $1.92M | 1.12% |
61,608
-1,176
| -2% | -$35.5K |
2013 Q2
7 quarters
|
|
|
10
State Street SPDR S&P Biotech ETF
XBI
$9.71B
| $1.72M | 1% |
22,890
-2,076
| -8% | -$145K |
2013 Q2
7 quarters
|
|
11
Elevance Health
ELV
$92.8B
| $1.71M | 1% |
11,070
-850
| -7% | -$121K |
2014 Q4
1 quarter
|
|
|
12
State Street Health Care Select Sector SPDR ETF
XLV
$45B
| $1.64M | 0.96% |
22,638
+729
| +3% | +$52K |
2013 Q2
7 quarters
|
|
13
Alphabet (Google) Class C
GOOG
$4.2T
| $1.59M | 0.93% |
57,899
+983
| +2% | +$26.3K |
2013 Q2
7 quarters
|
|
14
Walt Disney
DIS
$188B
| $1.54M | 0.9% |
14,671
-890
| -6% | -$89.8K |
2013 Q2
7 quarters
|
|
15
Target
TGT
$70.6B
| $1.47M | 0.86% |
17,910
-1,145
| -6% | -$88.4K |
2013 Q2
7 quarters
|
|
16
CVS Health
CVS
$116B
| $1.46M | 0.85% |
14,160
-1,235
| -8% | -$125K |
2014 Q1
4 quarters
|
|
17
Exelon
EXC
$43.9B
| $1.41M | 0.82% |
58,939
-4,569
| -7% | -$113K |
2013 Q2
7 quarters
|
|
18
3M
MMM
$84.8B
| $1.35M | 0.79% |
9,795
-269
| -3% | -$37.1K |
2013 Q2
7 quarters
|
|
|
19
GE Aerospace
GE
$319B
| $1.34M | 0.78% |
11,296
+315
| +3% | +$37.5K |
2013 Q2
7 quarters
|
|
20
Intel
INTC
$519B
| $1.31M | 0.77% |
42,000
-1,043
| -2% | -$35.2K |
2013 Q2
7 quarters
|
|
21
Zimmer Biomet
ZBH
$17.5B
| $1.28M | 0.75% |
11,242
-402
| -3% | -$45.9K |
2013 Q2
7 quarters
|
|
|
TWC
22
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $1.27M | 0.74% |
8,495
-985
| -10% | -$147K |
2014 Q1
4 quarters
|
|
23
Cisco
CSCO
$448B
| $1.27M | 0.74% |
46,217
-688
| -1% | -$19.4K |
2013 Q2
7 quarters
|
|
24
PepsiCo
PEP
$176B
| $1.27M | 0.74% |
13,301
-340
| -2% | -$32.9K |
2013 Q2
7 quarters
|
|
25
Johnson & Johnson
JNJ
$612B
| $1.24M | 0.72% |
12,320
-230
| -2% | -$23.4K |
2013 Q2
7 quarters
|
|
Similar funds
VU
ITC
CIAM
LOAMU
CCP
KF
IA
MHS
Proffitt & Goodson's Q1 2015 Portfolio in Review
As of Q1 2015, Proffitt & Goodson held 40 positions worth $172M, up 1.3% from $169M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 0%. Proffitt & Goodson opened no new positions and made no exits, leaving the 40-position portfolio largely intact.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, up from 78% a quarter earlier, followed by Technology and Healthcare.
- Proffitt & Goodson added most to Vanguard FTSE Developed Markets ETF in Q1 2015, an estimated $3.39M increase.
- Proffitt & Goodson's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11M.
- Proffitt & Goodson's ten largest holdings make up 78% of its $172M portfolio in Q1 2015.
- Proffitt & Goodson opened 0 new positions and closed 0 in Q1 2015.
- Proffitt & Goodson's portfolio value rose 1.3% quarter-over-quarter to $172M.
Based on Proffitt & Goodson's 13F filing for Q1 2015, filed 27 Apr 2015.